Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongmei Fan

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Oncoimmunology|June 5, 2023
Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinomaXiangfei Yuan, Yang Lu, Yuanyuan Yang, et al.
Molecular Pharmaceutics|November 6, 2012
Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphomaCihui Yan, Shuangjing Li, Zhenzhen Li, et al.
European Journal of Medicinal Chemistry|May 5, 2024
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS levelLidan Zhang, Pingxian Liu, Yunhan Jiang, et al.
Cancer Biology & Therapy|July 18, 2015
The novel structure make LDM effectively remove CD123+ AML stem cells in combination with interleukin 3Yanjun Zhang, Rong Liu, Dongmei Fan, et al.
Cancer Letters|January 26, 2002
Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 x anti-CD3 bispecific diabodyDongsheng Xiong, Yuanfu Xu, Hanzhi Liu, et al.
European Journal of Pharmacology|August 6, 2013
PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen speciesHongwei Peng, Xiangfei Yuan, Ruizan Shi, et al.
Cancer Letters|July 25, 2016
Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specificallyXiangfei Yuan, Qing Zhang, Zhenzhen Li, et al.
Acta Biomaterialia|March 31, 2010
Evaluation of mesoporous silicon/polycaprolactone composites as ophthalmic implantsSoheila Kashanian, Frances Harding, Yazad Irani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Efficient inhibition of human B-cell lymphoma in SCID mice by synergistic antitumor effect of human 4-1BB ligand/anti-CD20 fusion proteins and anti-CD3/anti-CD20 diabodiesRong Liu, Wenguo Jiang, Ming Yang, et al.
DNA and Cell Biology|June 27, 2020
Different Clinical Phenotypes Caused by Three <i>F8</i> Missense Mutations in Three Chinese Families with Moderate Hemophilia ALimin Huang, Liyan Li, Qiang Li, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Oncoimmunology|June 5, 2023
Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinomaXiangfei Yuan, Yang Lu, Yuanyuan Yang, et al.
Molecular Pharmaceutics|November 6, 2012
Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphomaCihui Yan, Shuangjing Li, Zhenzhen Li, et al.
European Journal of Medicinal Chemistry|May 5, 2024
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS levelLidan Zhang, Pingxian Liu, Yunhan Jiang, et al.
Cancer Biology & Therapy|July 18, 2015
The novel structure make LDM effectively remove CD123+ AML stem cells in combination with interleukin 3Yanjun Zhang, Rong Liu, Dongmei Fan, et al.
Cancer Letters|January 26, 2002
Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 x anti-CD3 bispecific diabodyDongsheng Xiong, Yuanfu Xu, Hanzhi Liu, et al.
European Journal of Pharmacology|August 6, 2013
PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen speciesHongwei Peng, Xiangfei Yuan, Ruizan Shi, et al.
Cancer Letters|July 25, 2016
Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specificallyXiangfei Yuan, Qing Zhang, Zhenzhen Li, et al.
Acta Biomaterialia|March 31, 2010
Evaluation of mesoporous silicon/polycaprolactone composites as ophthalmic implantsSoheila Kashanian, Frances Harding, Yazad Irani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Efficient inhibition of human B-cell lymphoma in SCID mice by synergistic antitumor effect of human 4-1BB ligand/anti-CD20 fusion proteins and anti-CD3/anti-CD20 diabodiesRong Liu, Wenguo Jiang, Ming Yang, et al.
DNA and Cell Biology|June 27, 2020
Different Clinical Phenotypes Caused by Three <i>F8</i> Missense Mutations in Three Chinese Families with Moderate Hemophilia ALimin Huang, Liyan Li, Qiang Li, et al.
Pageof 11